OpenAlexmetadata only
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Empagliflozin, Medicine, Hazard ratio, Myocardial infarction, Internal medicine, Placebo
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 6883
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.